Peptides AcademyStopping a GLP-1 Without Regaining the Weight
Many people who start semaglutide or tirzepatide stop within a year or two, because of cost, coverage, side effects, supply, or because they reached their goal. The trials are clear about what usually happens next. This guide covers what they show, why the weight comes back, and a 16-week off-ramp built around the four things you can control.
What happens when you stop
Three randomized trials stopped the drug on purpose and followed people afterwards. None of them gave participants an off-ramp plan; they simply stopped.
STEP 1 extension
semaglutideAfter 68 weeks of semaglutide 2.4 mg, treatment stopped and participants were followed for another year with no drug and no structured lifestyle program.
Within a year of stopping, participants had regained about two-thirds of the weight they had lost. Improvements in blood pressure, blood sugar and cholesterol drifted back toward where they started.
Trial summarySTEP 4
semaglutideEveryone took semaglutide 2.4 mg for 20 weeks and lost about 10.6% of body weight. Participants were then randomized to keep taking it or switch to placebo for 48 weeks.
Those who continued lost a further 7.9%. Those switched to placebo regained 6.9% of body weight over the same 48 weeks.
SURMOUNT-4
tirzepatideEveryone took tirzepatide at the highest tolerated dose (10 or 15 mg) for 36 weeks and lost about 20.9% of body weight. Participants were then randomized to continue or switch to placebo for 52 weeks.
Those who continued lost a further 5.5%. Those switched to placebo regained 14% of body weight, though most still weighed less than when they started.
Trial summaryTwo caveats. The averages hide a wide spread: some people regained almost nothing, others more than they had lost. And tapering, or a structured plan for the months after stopping, has not yet been tested against stopping outright in a randomized trial; what exists so far is observational.
Why the weight comes back
Appetite signaling returns
The drug quiets hunger and increases fullness only while it is in your system. As it clears, the brain's drive to regain lost weight is no longer being held back.
You need less energy now
A smaller body burns less, and any muscle lost along the way lowers it further. Eating the way you did before the drug now means a surplus.
Habits were built on a suppressed appetite
Eating less was easy because the drug made it easy. Without a plan for real hunger, portions and snacking creep back.
Four things that decide whether it stays off
Plan the stop with your prescriber
Decide together whether to step down, drop to a lower maintenance dose, or stop outright, and what happens if the weight starts to come back. If you take the drug for type 2 diabetes, the plan has to replace its effect on blood sugar too.
Off-Ramp ChecklistProtect the muscle you have
A meaningful share of the weight lost on a GLP-1 can be lean tissue, and lean tissue sets how much you can eat without regaining. Eat 1.2–1.6 g of protein per kg of body weight a day and lift weights three times a week.
Protein targetsPrepare for hunger coming back
Appetite and food noise return as drug levels fall, usually within a few weeks of the last dose. Protein- and fiber-first meals, a plan for evenings and weekends, and enough sleep carry most of the load.
What to eat after stoppingWatch the trend, with a threshold agreed in advance
Track a 7-day average weight rather than single weigh-ins, review it weekly, and agree in advance on the number that means "call the prescriber", for example 5% above your stop weight. Deciding early turns a panic into a plan.
The 16-week calendarShould you taper off or stop cold turkey?
Stopping a GLP-1 outright is not dangerous in the way stopping some medicines is. There is no recognized withdrawal syndrome, and because semaglutide and tirzepatide last days in the body, stopping already lets levels fall over several weeks.
A step-down goes further. It runs the titration ladder in reverse, typically about four weeks per dose, so appetite returns more slowly while new habits bed in. It also answers a useful question: whether a lower dose holds your weight at a lower cost. What it has not done yet is prove, in a randomized trial, that less weight comes back in the end.
The Taper Planner lays out a gradual and a shorter step-down from every dose of Zepbound, Wegovy, Ozempic and Mounjaro to take to your prescriber.
The 16-week off-ramp
Week 1 is the week you and your prescriber agree the plan. Four phases, each with a job to finish before the next begins.
- 01Weeks 1–2
Plan the stop
Agree the plan with your prescriber before the last full dose.
- Take the Off-Ramp Checklist to your appointment and decide together: taper, lower maintenance dose, or stop.
- Record your stop weight as a 7-day average, not a single morning.
- Agree a regain threshold in advance, for example a 7-day average 5% above your stop weight, and what happens if you cross it.
- 02Weeks 3–4
Build the floor
Set up the habits that have to be running before appetite comes back.
- Hit your protein target on most days (see the protein table).
- Train with weights three times a week to protect the muscle that sets your energy needs.
- Work fiber up toward 25–38 g a day, slowly, to limit bloating.
- 03Weeks 5–10
Ride out returning hunger
Appetite and "food noise" usually return as drug levels fall. This is the window where most regain starts.
- Eat on a plan rather than on cue: three protein-first meals and a planned snack.
- Name your three highest-risk situations (evenings, weekends, stress) and decide in advance what you will do in each.
- Protect sleep, keep alcohol low, and keep trigger foods out of easy reach.
- 04Weeks 11–16
Hold the line
Find the intake that holds your weight now that the drug is not doing the work.
- Review the 7-day average once a week. React to the trend, not to single days.
- If the average crosses your threshold, call your prescriber rather than crash-dieting.
- At week 16, decide with your prescriber whether to stay off, use a maintenance dose, or restart.
Stopping your specific GLP-1
Stopping Zepbound
tirzepatideHalf-life about 5 days, clears in about 4 weeks. Step-downs from 15 mg.
Stopping Wegovy
semaglutideHalf-life about 1 week, clears in about 5 weeks. Step-downs from 2.4 mg.
Stopping Ozempic
semaglutideHalf-life about 1 week, clears in about 5 weeks. Step-downs from 2 mg, plus what stopping means for blood sugar.
Stopping Mounjaro
tirzepatideHalf-life about 5 days, clears in about 4 weeks. Step-downs from 15 mg, plus what stopping means for blood sugar.
Stopping a GLP-1: common questions
What happens when you stop taking a GLP-1?
Appetite comes back as the drug clears, which takes roughly 4 weeks for tirzepatide (Zepbound, Mounjaro) and 5 weeks for semaglutide (Wegovy, Ozempic). In the withdrawal trials most people then regained a substantial part of the weight within a year: about two-thirds of the loss in the STEP 1 extension, and 14% of body weight in the placebo group of SURMOUNT-4. Improvements in blood pressure, blood sugar and cholesterol also drifted back. The average hides a wide spread, and the trial participants stopped without any structured plan.
Should I taper off a GLP-1 or stop cold turkey?
Both are used in practice, and no randomized trial has compared them yet. Because semaglutide and tirzepatide have long half-lives, stopping outright already lets blood levels fall gradually over several weeks. A step-down, which runs the titration ladder in reverse, makes that slower and gives you time to build habits while appetite returns, and it can reveal a lower dose that holds your weight. Decide with your prescriber; the Taper Planner has the step-down schedules for each dose.
How long does it take for a GLP-1 to leave your body?
A drug is largely cleared after about five half-lives. Semaglutide has a half-life of about a week, so it takes around five weeks; tirzepatide’s is about five days, so around four weeks. Many people notice appetite returning before the drug is fully gone.
Will I gain all the weight back after stopping?
Not necessarily, but most people in the trials regained a large share. In SURMOUNT-4, people switched to placebo regained 14% of body weight over a year, yet most still weighed less than before they started tirzepatide. Results varied widely between individuals. Strength training, adequate protein, and an early response to a rising trend are the parts you control.
How can I keep the weight off after stopping Ozempic, Wegovy or Zepbound?
Plan the stop with your prescriber, protect muscle with protein and resistance training, prepare for appetite returning in the weeks after the last dose, and track a 7-day average weight against a threshold you agree in advance. In one Danish trial of liraglutide, people who had exercised alongside the drug kept more of their loss a year after stopping than those who took the drug alone.
How much protein should I eat after stopping a GLP-1?
A common target for protecting muscle during and after weight loss is 1.2–1.6 g per kg of body weight a day, split across meals. With a BMI above 30, dietitians often base it on a goal or adjusted weight instead. If you have kidney disease, agree a target with your clinician. The Taper Planner has a table by body weight.
Can I restart a GLP-1 if the weight comes back?
Usually yes, if your prescriber and coverage allow it. After a break of more than a couple of weeks, prescribers normally restart at a lower dose and step back up to limit nausea and other gastrointestinal side effects. Agreeing the restart rule before you stop is part of the checklist.
Can natural GLP-1 supplements replace the injection?
No. Berberine, fiber and probiotic products may nudge your own GLP-1 release, but the body clears natural GLP-1 within minutes, while semaglutide and tirzepatide are engineered to last days. The effects are not comparable. See our evidence review of natural GLP-1 supplements.
Educational content only, not medical advice. Whether and how to reduce or stop a prescription GLP-1 is a decision for you and your prescriber, especially if you take it for type 2 diabetes or take other glucose-lowering medicines. The step-down tables mirror the label dose ladders in reverse; they are a starting point for that conversation, not a prescription.